Publications by authors named "Curly Morris"

Claim this Profile
S
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Matjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, Linda Koster, Frantisek Folber, Curly Morris

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.
Sarah Lawless, Simona Iacobelli, Nina Simone Knelange, Patrice Chevallier, Didier Blaise, Curly Morris

Haematologica· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial.
Judith Behrens, Gill Gaskin, Neil Iggo, Jonathan Barratt, Jane Tighe, Curly Morris

EJHaem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgD multiple myeloma: biology, diagnosis, and treatment.
Philip A Egan, Sheila J M O'Connor, W Ian Deighan, Conal E McConville, Patrick T Elder, T C M Curly Morris

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
Anna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, Linda Koster, Didier Blaise, Curly Morris

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study.
Sarah Lawless, Giulia Sbianchi, Curly Morris, Simona Iacobelli, Paul Bosman

Clin Lymphoma Myeloma Leuk· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution or revolution in multiple myeloma therapy and the role of the UK.
Gordon Cook, Curly T C M Morris

Br J Haematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT.
Laurent Garderet, Curly Morris, Meral Beksac, Gösta Gahrton, Stefan Schönland

Biol Blood Marrow Transplant· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor.
Curly Morris, Christian Chabannon, Tamas Masszi, Nigel Russell, Hareth Nahi

Bone Marrow Transplant· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Firoozeh Sahebi, Simona Iacobelli, Giulia Sbianchi, Linda Koster, Didier Blaise, Curly Morris

Biol Blood Marrow Transplant· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan 140 mg/m or 200 mg/m for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Holger W Auner, Simona Iacobelli, Giulia Sbianchi, Cora Knol-Bout, Didier Blaise, Curly Morris

Haematologica· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances.
Laurent Garderet, Anita D'Souza, Paulette Jacobs, Anja van Biezen, Stefan Schönland, Curly Morris

Biol Blood Marrow Transplant· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting.
Laurent Garderet, Gordon Cook, Holger W Auner, Benedetto Bruno, Henk Lokhorst, Curly Morris

Leuk Lymphoma· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).
Benedetto Bruno, Holger W Auner, Gösta Gahrton, Laurent Garderet, Moreno Festuccia, Curly Morris

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Gordon Cook, Simona Iacobelli, Anja van Biezen, Dimitris Ziagkos, Veronique LeBlond, Curly Morris

Haematologica· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial.
Christopher Parrish, Curly T C M Morris, Cathy D Williams, David A Cairns, Jamie Cavenagh

Biol Blood Marrow Transplant· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial.
Steve Schey, Sarah R Brown, Avie-Lee Tillotson, Kwee Yong, Cathy Williams, Curly Morris

Br J Haematol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Curly Morris, Simona Iacobelli, Gösta Gahrton, Anja van Biezen, Mary Drake

Biol Blood Marrow Transplant· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Curly Morris, Liesbeth de Wreede, Marijke Scholten, Ronald Brand, Anja van Biezen

Transfusion· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.
Gösta Gahrton, Simona Iacobelli, Bo Björkstrand, Ute Hegenbart, Astrid Gruber, Curly Morris

Blood· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Laurent Garderet, Simona Iacobelli, Philippe Moreau, Mamoun Dib, Ingrid Lafon, Curly Morris

J Clin Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Bo Björkstrand, Simona Iacobelli, Ute Hegenbart, Astrid Gruber, Hildegard Greinix, Curly Morris

J Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-transplantation after bortezomib-based therapy.
Curly Morris, Gordon Cook, Matthew Streetly, Paul Kettle, Mary Drake

Br J Haematol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and outcome of autologous transplantation in rare myelomas.
Curly Morris, Mary Drake, Jane Apperley, Simona Iacobelli, Anja van Biezen

Haematologica· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary plasma cell leukemia and autologous stem cell transplantation.
Mary B Drake, Simona Iacobelli, Anja van Biezen, Curly Morris, Jane F Apperley

Haematologica· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis